NORIS, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.999
AS - Asia 5.581
EU - Europa 4.259
SA - Sud America 680
AF - Africa 149
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.697
Nazione #
US - Stati Uniti d'America 6.829
CN - Cina 2.816
SG - Singapore 1.180
IE - Irlanda 965
HK - Hong Kong 584
FI - Finlandia 514
BR - Brasile 499
DE - Germania 498
UA - Ucraina 485
VN - Vietnam 464
IT - Italia 413
RU - Federazione Russa 395
SE - Svezia 306
FR - Francia 253
GB - Regno Unito 205
IN - India 127
CA - Canada 104
AR - Argentina 84
BD - Bangladesh 81
ZA - Sudafrica 70
IQ - Iraq 53
JP - Giappone 36
MX - Messico 35
NL - Olanda 32
EC - Ecuador 30
PL - Polonia 30
TR - Turchia 30
PK - Pakistan 26
ES - Italia 24
ID - Indonesia 24
SA - Arabia Saudita 24
UZ - Uzbekistan 21
BE - Belgio 20
AU - Australia 18
CO - Colombia 18
PH - Filippine 18
RO - Romania 17
MA - Marocco 16
CZ - Repubblica Ceca 15
AT - Austria 13
EG - Egitto 13
IR - Iran 11
AZ - Azerbaigian 10
JO - Giordania 10
KE - Kenya 10
PE - Perù 10
VE - Venezuela 10
ET - Etiopia 9
EU - Europa 9
GR - Grecia 9
LT - Lituania 9
MY - Malesia 9
PY - Paraguay 9
AL - Albania 8
CH - Svizzera 8
CL - Cile 8
PA - Panama 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
UY - Uruguay 7
KG - Kirghizistan 6
NP - Nepal 6
DZ - Algeria 5
HU - Ungheria 5
KR - Corea 5
KZ - Kazakistan 5
LB - Libano 5
MU - Mauritius 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
DK - Danimarca 3
HN - Honduras 3
JM - Giamaica 3
LU - Lussemburgo 3
MD - Moldavia 3
RS - Serbia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
BB - Barbados 1
Totale 17.677
Città #
Dublin 965
Chandler 874
San Jose 827
Jacksonville 662
Singapore 650
Nanjing 615
Ashburn 612
Hong Kong 566
Dallas 525
Beijing 426
Boardman 284
Nanchang 224
Princeton 194
Shenyang 184
Wilmington 182
Lawrence 180
Medford 178
Munich 176
Changsha 165
Hebei 165
Lauterbourg 165
Ho Chi Minh City 160
Helsinki 156
Los Angeles 156
Jiaxing 128
Hanoi 125
New York 96
Tianjin 96
Council Bluffs 93
Hangzhou 91
Ann Arbor 89
Milan 87
Buffalo 76
Pavia 66
Shanghai 65
São Paulo 63
Johannesburg 57
Moscow 56
Redondo Beach 53
Houston 49
Orem 47
Woodbridge 47
Turku 43
Chennai 35
Toronto 35
Guangzhou 33
Montreal 33
Santa Clara 33
Tokyo 33
Verona 33
Fairfield 28
The Dalles 28
Da Nang 27
Seattle 26
Brooklyn 25
Denver 25
Frankfurt am Main 25
Norwalk 25
London 24
Warsaw 21
Pune 20
San Francisco 20
Belo Horizonte 19
Phoenix 19
Zhengzhou 19
Ankara 18
Atlanta 18
Baghdad 18
Brussels 18
Chicago 18
Tashkent 18
Brasília 17
Falkenstein 17
Manchester 17
Mexico City 17
Rome 17
Haiphong 16
Jinan 16
Des Moines 15
Rio de Janeiro 15
Stockholm 15
Columbus 14
Brno 13
Falls Church 12
Mumbai 12
Nuremberg 12
Timisoara 12
Auburn Hills 11
Quito 11
Secaucus 11
Amsterdam 10
Biên Hòa 10
Buenos Aires 10
Dhaka 10
Kunming 10
Paris 10
Sydney 10
Amman 9
Boston 9
Fuzhou 9
Totale 11.779
Nome #
Anemia in patients with Covid-19: pathogenesis and clinical significance 288
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 173
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 166
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 163
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 162
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 160
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 148
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 148
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 141
Antigeni minori di istocompatibilità 140
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 140
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 139
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 139
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 138
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 138
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 138
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 133
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 133
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 130
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 130
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 127
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 125
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 124
Spectrum of the mutations in Bernard-Soulier syndrome. 123
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 123
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 122
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 121
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 119
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 118
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 118
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 118
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 117
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 117
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 117
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 117
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 116
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 115
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 115
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 115
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 115
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 115
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 115
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 114
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 113
Inherited thrombocytopenias. The evolving spectrum. 113
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 112
Platelet-independent defect in hemostasis associated with sirolimus use 111
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 110
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 109
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 108
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 108
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 107
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 107
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk disorders. In patients the SPATA-DVT with inherited Study platelet 107
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 105
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 105
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 105
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 104
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 104
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 103
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 102
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 101
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 101
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 101
null 100
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 100
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 100
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 99
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 99
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 99
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 99
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 98
In vitro and in vivo effects of desmopressin on platelet function 98
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 97
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 97
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 97
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 96
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 96
Platelet count and aging 95
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 95
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 95
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 95
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 94
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 94
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 93
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 93
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 92
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 92
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 91
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 91
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 91
ANKRD26-related thrombocytopenia and myeloid malignancies 91
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 90
A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders 90
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 90
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function 89
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 89
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 89
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 88
Totale 11.461
Categoria #
all - tutte 77.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022913 24 1 32 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/20252.556 48 230 53 84 52 178 141 201 534 89 321 625
2025/20266.382 499 432 827 731 716 305 1.296 287 524 436 212 117
Totale 18.126